{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:51:41Z","timestamp":1793389901657,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Health and Medical Research Council (AU)","award":["ID 1081710"],"award-info":[{"award-number":["ID 1081710"]}]},{"name":"National Health and Medical Research Council (AU)","award":["1005329"],"award-info":[{"award-number":["1005329"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["ID1043026"],"award-info":[{"award-number":["ID1043026"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asian, China","award":["SKL-HIDCA-2017-Y11"],"award-info":[{"award-number":["SKL-HIDCA-2017-Y11"]}]},{"name":"Nature Science Foundation of Xinjiang, China","award":["2018D01C197"],"award-info":[{"award-number":["2018D01C197"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00395-019-0739-9","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T07:17:02Z","timestamp":1560928622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Relaxin mitigates microvascular damage and inflammation following cardiac ischemia\u2013reperfusion"],"prefix":"10.1007","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-0525","authenticated-orcid":false,"given":"Xiao-Ming","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Kiriazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanguli","family":"Ruze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Bin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"739_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1111\/j.1476-5381.1995.tb16377.x","volume":"116","author":"T Bani-Sacchi","year":"1995","unstructured":"Bani-Sacchi T, Bigazzi M, Bani D, Mannaioni PF, Masini E (1995) Relaxin-induced increased coronary flow through stimulation of nitric oxide production. Br J Pharmacol 116:1589\u20131594. \n                    https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb16377.x","journal-title":"Br J Pharmacol"},{"key":"739_CR2","first-page":"709","volume":"73","author":"D Bani","year":"1995","unstructured":"Bani D, Bigazzi M, Masini E, Bani G, Sacchi TB (1995) Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets. Lab Investig 73:709\u2013716","journal-title":"Lab Investig"},{"key":"739_CR3","first-page":"1367","volume":"152","author":"D Bani","year":"1998","unstructured":"Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB (1998) Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart. Am J Pathol 152:1367\u20131376","journal-title":"Am J Pathol"},{"key":"739_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijcard.2017.09.017","volume":"250","author":"T Beiert","year":"2018","unstructured":"Beiert T, Knappe V, Tiyerili V, Stockigt F, Effelsberg V, Linhart M, Steinmetz M, Klein S, Schierwagen R, Trebicka J, Roell W, Nickenig G, Schrickel JW, Andrie RP (2018) Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties. Int J Cardiol 250:21\u201328. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2017.09.017","journal-title":"Int J Cardiol"},{"key":"739_CR5","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.jacc.2009.12.037","volume":"55","author":"SC Bekkers","year":"2010","unstructured":"Bekkers SC, Yazdani SK, Virmani R, Waltenberger J (2010) Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol 55:1649\u20131660. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2009.12.037","journal-title":"J Am Coll Cardiol"},{"key":"739_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","volume":"113","author":"HE Botker","year":"2018","unstructured":"Botker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femmino S, Garcia-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuhauser M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schluter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G (2018) Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res Cardiol 113:39. \n                    https:\/\/doi.org\/10.1007\/s00395-018-0696-8","journal-title":"Basic Res Cardiol"},{"key":"739_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.regpep.2010.09.001","volume":"166","author":"A Brecht","year":"2011","unstructured":"Brecht A, Bartsch C, Baumann G, Stangl K, Dschietzig T (2011) Relaxin inhibits early steps in vascular inflammation. Regul Pept 166:76\u201382. \n                    https:\/\/doi.org\/10.1016\/j.regpep.2010.09.001","journal-title":"Regul Pept"},{"key":"739_CR8","doi-asserted-by":"publisher","first-page":"e002834","DOI":"10.1161\/JAHA.115.002834","volume":"5","author":"D Carrick","year":"2016","unstructured":"Carrick D, Haig C, Ahmed N, Rauhalammi S, Clerfond G, Carberry J, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay MM, Mahrous A, Welsh P, Sattar N, Ford I, Oldroyd KG, Radjenovic A, Berry C (2016) Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-segment elevation myocardial infarction: pathophysiological insights and clinical implications. J Am Heart Assoc 5:e002834. \n                    https:\/\/doi.org\/10.1161\/JAHA.115.002834","journal-title":"J Am Heart Assoc"},{"key":"739_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jneumeth.2015.05.011","volume":"251","author":"MA Collins","year":"2015","unstructured":"Collins MA, An J, Peller D, Bowser R (2015) Total protein is an effective loading control for cerebrospinal fluid western blots. J Neurosci Methods 251:72\u201382. \n                    https:\/\/doi.org\/10.1016\/j.jneumeth.2015.05.011","journal-title":"J Neurosci Methods"},{"key":"739_CR10","doi-asserted-by":"publisher","first-page":"R250","DOI":"10.1152\/ajpregu.00672.2003","volume":"287","author":"KP Conrad","year":"2004","unstructured":"Conrad KP, Novak J (2004) Emerging role of relaxin in renal and cardiovascular function. Am J Physiol Regul Integr Comp Physiol 287:R250\u2013R261. \n                    https:\/\/doi.org\/10.1152\/ajpregu.00672.2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"739_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ijcard.2017.01.079","volume":"236","author":"W Dai","year":"2017","unstructured":"Dai W, Hale S, Kloner RA (2017) Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia\/reperfusion model. Int J Cardiol 236:400\u2013404. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2017.01.079","journal-title":"Int J Cardiol"},{"key":"739_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/cvr\/cvs149","volume":"95","author":"T Dschietzig","year":"2012","unstructured":"Dschietzig T, Brecht A, Bartsch C, Baumann G, Stangl K, Alexiou K (2012) Relaxin improves TNF-alpha-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling. Cardiovasc Res 95:97\u2013107. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvs149","journal-title":"Cardiovasc Res"},{"key":"739_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11427-017-9223-x","volume":"31","author":"XJ Du","year":"2018","unstructured":"Du XJ (2018) Post-infarct cardiac injury, protection and repair: roles of non-cardiomyocyte multicellular and acellular components. Sci China Life Sci 31:266\u2013276. \n                    https:\/\/doi.org\/10.1007\/s11427-017-9223-x","journal-title":"Sci China Life Sci"},{"key":"739_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2009.198","volume":"7","author":"XJ Du","year":"2010","unstructured":"Du XJ, Bathgate RA, Samuel CS, Dart AM, Summers RJ (2010) Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol 7:48\u201358. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2009.198","journal-title":"Nat Rev Cardiol"},{"key":"739_CR15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1253\/circj.CJ-14-0014","volume":"78","author":"XJ Du","year":"2014","unstructured":"Du XJ, Hewitson TD, Nguyen MN, Samuel CS (2014) Therapeutic effects of serelaxin in acute heart failure. Circ J 78:542\u2013552. \n                    https:\/\/doi.org\/10.1253\/circj.CJ-14-0014","journal-title":"Circ J"},{"key":"739_CR16","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.2507","volume":"17","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Eckle T (2011) Ischemia and reperfusion\u2014from mechanism to translation. Nat Med 17:1391\u20131401. \n                    https:\/\/doi.org\/10.1038\/nm.2507","journal-title":"Nat Med"},{"key":"739_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1096\/fj.01-0569fje","volume":"16","author":"P Failli","year":"2002","unstructured":"Failli P, Nistri S, Quattrone S, Mazzetti L, Bigazzi M, Sacchi TB, Bani D (2002) Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells. FASEB J 16:252\u2013254. \n                    https:\/\/doi.org\/10.1096\/fj.01-0569fje","journal-title":"FASEB J"},{"key":"739_CR18","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1084\/jem.183.5.1981","volume":"183","author":"D Feng","year":"1996","unstructured":"Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM (1996) Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183:1981\u20131986","journal-title":"J Exp Med"},{"key":"739_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/FJC.0b013e3182a50c45","volume":"62","author":"A Folino","year":"2013","unstructured":"Folino A, Losano G, Rastaldo R (2013) Balance of nitric oxide and reactive oxygen species in myocardial reperfusion injury and protection. J Cardiovasc Pharmacol 62:567\u2013575. \n                    https:\/\/doi.org\/10.1097\/FJC.0b013e3182a50c45","journal-title":"J Cardiovasc Pharmacol"},{"key":"739_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/ejechocard\/jer009","volume":"12","author":"S Funaro","year":"2011","unstructured":"Funaro S, Galiuto L, Boccalini F, Cimino S, Canali E, Evangelio F, DeLuca L, Paraggio L, Mattatelli A, Gnessi L, Agati L (2011) Determinants of microvascular damage recovery after acute myocardial infarction: results from the acute myocardial infarction contrast imaging (AMICI) multi-centre study. Eur J Echocardiogr 12:306\u2013312. \n                    https:\/\/doi.org\/10.1093\/ejechocard\/jer009","journal-title":"Eur J Echocardiogr"},{"key":"739_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.yjmcc.2010.12.022","volume":"50","author":"XM Gao","year":"2011","unstructured":"Gao XM, Liu Y, White D, Su Y, Drew BG, Bruce CR, Kiriazis H, Xu Q, Jennings N, Bobik A, Febbraio MA, Kingwell BA, Bucala R, Fingerle-Rowson G, Dart AM, Morand EF, Du XJ (2011) Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia\u2013reperfusion injury: a predominant role of anti-inflammation. J Mol Cell Cardiol 50:991\u2013999. \n                    https:\/\/doi.org\/10.1016\/j.yjmcc.2010.12.022","journal-title":"J Mol Cell Cardiol"},{"key":"739_CR22","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1042\/CS20160234","volume":"130","author":"XM Gao","year":"2016","unstructured":"Gao XM, Moore XL, Liu Y, Wang XY, Han LP, Su Y, Tsai A, Xu Q, Zhang M, Lambert GW, Kiriazis H, Gao W, Dart AM, Du XJ (2016) Splenic release of platelets contributes to increased circulating platelet size and inflammation after myocardial infarction. Clin Sci (Lond) 130:1089\u20131104. \n                    https:\/\/doi.org\/10.1042\/CS20160234","journal-title":"Clin Sci (Lond)"},{"key":"739_CR23","doi-asserted-by":"publisher","first-page":"H1068","DOI":"10.1152\/ajpheart.00073.2017","volume":"312","author":"XM Gao","year":"2017","unstructured":"Gao XM, Wu QZ, Kiriazis H, Su Y, Han LP, Pearson JT, Taylor AJ, Du XJ (2017) Microvascular leakage in acute myocardial infarction: characterization by histology, biochemistry, and magnetic resonance imaging. Am J Physiol Heart Circ Physiol 312:H1068\u2013H1075. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00073.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"739_CR24","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1073\/pnas.91.15.7291","volume":"91","author":"C Garlanda","year":"1994","unstructured":"Garlanda C, Parravicini C, Sironi M, De Rossi M, de Wainstok Calmanovici R, Carozzi F, Bussolino F, Colotta F, Mantovani A, Vecchi A (1994) Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors. Proc Natl Acad Sci USA 91:7291\u20137295. \n                    https:\/\/doi.org\/10.1073\/pnas.91.15.7291","journal-title":"Proc Natl Acad Sci USA"},{"key":"739_CR25","doi-asserted-by":"publisher","first-page":"H421","DOI":"10.1152\/ajpheart.00962.2007","volume":"294","author":"SL Hale","year":"2008","unstructured":"Hale SL, Mehra A, Leeka J, Kloner RA (2008) Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia\u2013reperfusion. Am J Physiol Heart Circ Physiol 294:H421\u2013H425. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00962.2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"739_CR26","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jcmg.2014.06.012","volume":"7","author":"YS Hamirani","year":"2014","unstructured":"Hamirani YS, Wong A, Kramer CM, Salerno M (2014) Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis. JACC Cardiovasc Imaging 7:940\u2013952. \n                    https:\/\/doi.org\/10.1016\/j.jcmg.2014.06.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"739_CR27","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/cvr\/cvy286","volume":"115","author":"DJ Hausenloy","year":"2019","unstructured":"Hausenloy DJ, Chilian W, Crea F, Davidson SM, Ferdinandy P, Garcia-Dorado D, van Royen N, Schulz R, Heusch G (2019) The coronary circulation in acute myocardial ischaemia\/reperfusion injury: a target for cardioprotection. Cardiovasc Res 115:1143\u20131155. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvy286","journal-title":"Cardiovasc Res"},{"key":"739_CR28","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/CIRCRESAHA.116.308640","volume":"118","author":"G Heusch","year":"2016","unstructured":"Heusch G (2016) The coronary circulation as a target of cardioprotection. Circ Res 118:1643\u20131658. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308640","journal-title":"Circ Res"},{"key":"739_CR29","doi-asserted-by":"publisher","first-page":"H499","DOI":"10.1152\/ajpheart.00325.2011","volume":"302","author":"T Hirase","year":"2012","unstructured":"Hirase T, Node K (2012) Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol 302:H499\u2013H505. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00325.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"739_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0083-6729(08)60670-6","volume":"8","author":"FL Hisaw","year":"1950","unstructured":"Hisaw FL, Zarrow MX (1950) The physiology of relaxin. Vitam Horm 8:151\u2013178. \n                    https:\/\/doi.org\/10.1016\/S0083-6729(08)60670-6","journal-title":"Vitam Horm"},{"key":"739_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/1074248411405990","volume":"16","author":"RA Kloner","year":"2011","unstructured":"Kloner RA (2011) No-reflow phenomenon: maintaining vascular integrity. J Cardiovasc Pharmacol Ther 16:244\u2013250. \n                    https:\/\/doi.org\/10.1177\/1074248411405990","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"739_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pharmthera.2018.02.004","volume":"187","author":"M Lam","year":"2018","unstructured":"Lam M, Royce SG, Samuel CS, Bourke JE (2018) Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseases. Pharmacol Ther 187:61\u201370. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2018.02.004","journal-title":"Pharmacol Ther"},{"key":"739_CR33","doi-asserted-by":"publisher","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey ML, Bolli R, Canty JM Jr, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G (2018) Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol 314:H812\u2013H838. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00335.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"739_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00395-013-0383-8","volume":"108","author":"N Mewton","year":"2013","unstructured":"Mewton N, Thibault H, Roubille F, Lairez O, Rioufol G, Sportouch C, Sanchez I, Bergerot C, Cung TT, Finet G, Angoulvant D, Revel D, Bonnefoy-Cudraz E, Elbaz M, Piot C, Sahraoui I, Croisille P, Ovize M (2013) Postconditioning attenuates no-reflow in STEMI patients. Basic Res Cardiol 108:383. \n                    https:\/\/doi.org\/10.1007\/s00395-013-0383-8","journal-title":"Basic Res Cardiol"},{"key":"739_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10557-014-6525-x","volume":"28","author":"XL Moore","year":"2014","unstructured":"Moore XL, Su Y, Fan Y, Zhang YY, Woodcock EA, Dart AM, Du XJ (2014) Diverse regulation of cardiac expression of relaxin receptor by alpha1- and beta1-adrenoceptors. Cardiovasc Drugs Ther 28:221\u2013228. \n                    https:\/\/doi.org\/10.1007\/s10557-014-6525-x","journal-title":"Cardiovasc Drugs Ther"},{"key":"739_CR36","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.jacc.2009.12.054","volume":"55","author":"G Ndrepepa","year":"2010","unstructured":"Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J, Alger P, Mehilli J, Schomig A, Kastrati A (2010) 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55:2383\u20132389. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2009.12.054","journal-title":"J Am Coll Cardiol"},{"key":"739_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbrep.2017.09.001","volume":"12","author":"X Nie","year":"2017","unstructured":"Nie X, Li C, Hu S, Xue F, Kang YJ, Zhang W (2017) An appropriate loading control for western blot analysis in animal models of myocardial ischemic infarction. Biochem Biophys Rep 12:108\u2013113. \n                    https:\/\/doi.org\/10.1016\/j.bbrep.2017.09.001","journal-title":"Biochem Biophys Rep"},{"key":"739_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.phrs.2007.11.001","volume":"57","author":"S Nistri","year":"2008","unstructured":"Nistri S, Cinci L, Perna AM, Masini E, Mastroianni R, Bani D (2008) Relaxin induces mast cell inhibition and reduces ventricular arrhythmias in a swine model of acute myocardial infarction. Pharmacol Res 57:43\u201348. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2007.11.001","journal-title":"Pharmacol Res"},{"key":"739_CR39","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1096\/fj.04-3664fje","volume":"19","author":"AM Perna","year":"2005","unstructured":"Perna AM, Masini E, Nistri S, Briganti V, Chiappini L, Stefano P, Bigazzi M, Pieroni C, Bani Sacchi T, Bani D (2005) Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model. FASEB J 19:1525\u20131527. \n                    https:\/\/doi.org\/10.1096\/fj.04-3664fje","journal-title":"FASEB J"},{"key":"739_CR40","doi-asserted-by":"publisher","first-page":"14232","DOI":"10.1038\/ncomms14232","volume":"8","author":"CX Qin","year":"2017","unstructured":"Qin CX, May LT, Li R, Cao N, Rosli S, Deo M, Alexander AE, Horlock D, Bourke JE, Yang YH, Stewart AG, Kaye DM, Du XJ, Sexton PM, Christopoulos A, Gao XM, Ritchie RH (2017) Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia\u2013reperfusion injury in mice. Nat Commun 8:14232. \n                    https:\/\/doi.org\/10.1038\/ncomms14232","journal-title":"Nat Commun"},{"key":"739_CR41","doi-asserted-by":"publisher","first-page":"H1099","DOI":"10.1152\/ajpheart.00270.2002","volume":"283","author":"T Reffelmann","year":"2002","unstructured":"Reffelmann T, Kloner RA (2002) Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol 283:H1099\u2013H1107. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00270.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"739_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/labinvest.2010.198","volume":"91","author":"CS Samuel","year":"2011","unstructured":"Samuel CS, Cendrawan S, Gao XM, Ming Z, Zhao C, Kiriazis H, Xu Q, Tregear GW, Bathgate RA, Du XJ (2011) Relaxin remodels fibrotic healing following myocardial infarction. Lab Investig 91:675\u2013690. \n                    https:\/\/doi.org\/10.1038\/labinvest.2010.198","journal-title":"Lab Investig"},{"key":"739_CR43","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/bph.13523","volume":"174","author":"M Sarwar","year":"2017","unstructured":"Sarwar M, Du XJ, Dschietzig TB, Summers RJ (2017) The actions of relaxin on the human cardiovascular system. Br J Pharmacol 174:933\u2013949. \n                    https:\/\/doi.org\/10.1111\/bph.13523","journal-title":"Br J Pharmacol"},{"key":"739_CR44","doi-asserted-by":"publisher","first-page":"H871","DOI":"10.1152\/ajpheart.00293.2017","volume":"313","author":"A Skyschally","year":"2017","unstructured":"Skyschally A, Amanakis G, Neuhauser M, Kleinbongard P, Heusch G (2017) Impact of electrical defibrillation on infarct size and no-reflow in pigs subjected to myocardial ischemia\u2013reperfusion without and with ischemic conditioning. Am J Physiol Heart Circ Physiol 313:H871\u2013H878. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00293.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"739_CR45","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2741\/4615","volume":"23","author":"K Stark","year":"2018","unstructured":"Stark K, Pekayvaz K, Massberg S (2018) Role of pericytes in vascular immunosurveillance. Front Biosci (Landmark Ed) 23:767\u2013781. \n                    https:\/\/doi.org\/10.2741\/4615","journal-title":"Front Biosci (Landmark Ed)"},{"key":"739_CR46","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/cvr\/cvw246","volume":"113","author":"J Valle Raleigh","year":"2017","unstructured":"Valle Raleigh J, Mauro AG, Devarakonda T, Marchetti C, He J, Kim E, Filippone S, Das A, Toldo S, Abbate A, Salloum FN (2017) Reperfusion therapy with recombinant human relaxin-2 (serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia\/reperfusion injury via eNOS-dependent mechanism. Cardiovasc Res 113:609\u2013619. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvw246","journal-title":"Cardiovasc Res"},{"key":"739_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1537-1891(03)00014-4","volume":"39","author":"GP Nieuw Amerongen van","year":"2002","unstructured":"van Nieuw Amerongen GP, van Hinsbergh VW (2002) Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vasc Pharmacol 39:257\u2013272. \n                    https:\/\/doi.org\/10.1016\/S1537-1891(03)00014-4","journal-title":"Vasc Pharmacol"},{"key":"739_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/ATVBAHA.107.158014","volume":"28","author":"D Vestweber","year":"2008","unstructured":"Vestweber D (2008) VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28:223\u2013232. \n                    https:\/\/doi.org\/10.1161\/ATVBAHA.107.158014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"739_CR49","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nri2096","volume":"7","author":"C Weber","year":"2007","unstructured":"Weber C, Fraemohs L, Dejana E (2007) The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 7:467\u2013477. \n                    https:\/\/doi.org\/10.1038\/nri2096","journal-title":"Nat Rev Immunol"},{"key":"739_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yjmcc.2014.01.015","volume":"69","author":"DA White","year":"2014","unstructured":"White DA, Su Y, Kanellakis P, Kiriazis H, Morand EF, Bucala R, Dart AM, Gao XM, Du XJ (2014) Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction. J Mol Cell Cardiol 69:32\u201342. \n                    https:\/\/doi.org\/10.1016\/j.yjmcc.2014.01.015","journal-title":"J Mol Cell Cardiol"},{"key":"739_CR51","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jcin.2015.08.033","volume":"8","author":"T Yetgin","year":"2015","unstructured":"Yetgin T, Uitterdijk A, Te Lintel Hekkert M, Merkus D, Krabbendam-Peters I, van Beusekom HMM, Falotico R, Serruys PW, Manintveld OC, van Geuns RM, Zijlstra F, Duncker DJ (2015) Limitation of infarct size and no-reflow by intracoronary adenosine depends critically on dose and duration. JACC Cardiovasc Interv 8:1990\u20131999. \n                    https:\/\/doi.org\/10.1016\/j.jcin.2015.08.033","journal-title":"JACC Cardiovasc Interv"},{"key":"739_CR52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1590\/1414-431X20132999","volume":"47","author":"XJ Zhao","year":"2014","unstructured":"Zhao XJ, Liu XL, He GX, Xu HP (2014) Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion. Braz J Med Biol Res 47:245\u2013251. \n                    https:\/\/doi.org\/10.1590\/1414-431X20132999","journal-title":"Braz J Med Biol Res"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-019-0739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00395-019-0739-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-019-0739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T19:40:07Z","timestamp":1569267607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00395-019-0739-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s00395-019-0739-9","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"assertion":[{"value":"17 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"30"}}